Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT02201992||Recruiting||Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)||
||Other / NIH||
||168||All||18 Years and older (Adult, Older Adult)||NCT02201992||E4512
|August 18, 2014||May 1, 2022||July 28, 2014||February 6, 2019||